Sign Up Today and Learn More About Neuralink Stock
Invest in or calculate the value of your shares in Neuralink or other pre-IPO companies through EquityZen's platform.
About Neuralink Stock
Founded
2017
Headquarters
San Francisco, CA, US
Total Funding
688M
Industries
Hardware, Software, Science and Engineering
Neuralink is developing the capabilities of the brain through technological augmentation. A "neural lace” would be surgically connected to a human brain and allow a user to interact with a computer without the bandwidth challenges that come with current input methods, including keyboards, mice and trackpads. Neuralink will explore how brain interfaces might alleviate the symptoms of dangerous and chronic medical conditions. Source: [TechCrunch](https://techcrunch.com/2017/03/27/elon-musks-neuralink-wants-to-boost-the-brain-to-keep-up-with-ai/)
Neuralink Press Mentions
Stay in the know about the latest news on Neuralink
Why Elon Musk is the real winner of the 2024 US Presidential election
mashable • Nov 12, 2024
Graphene implants decode the complexities of the human brain
longevity • Nov 09, 2024
Trump victory expected to boost Musk's Mars dream
zawya • Nov 08, 2024
What Elon Musk gains from a second Trump term
mashable • Nov 08, 2024
Elon Musk joining Trump's team would not impact EU Commission's X probes
euronews • Nov 08, 2024
Investors in Neuralink
Discover investors in Neuralink stock and explore their portfolio companies
Neuralink Management
Leadership team at Neuralink
Founder
Elon Musk
Join now and verify your accreditation status to gain access to:
- Neuralink current valuation
- Neuralink stock price
- Available deals in Neuralink and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Neuralink stock?
Accredited investors can buy pre-IPO stock in companies like Neuralink through EquityZen funds. These investments are made available by existing Neuralink shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Neuralink stock?
Shareholders can sell their Neuralink stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
